Epidermal Growth Factor Receptor (EGFR) Cell Expression During Adjuvant Treatment After Transurethral Resection for Non-Muscle-Invasive Bladder Cancer: A New Potential Tool to Identify Patients at Higher Risk of Disease Progression

Vincenzo Serretta, Rosalinda Allegro, Antonio Russo, Antonina Cangemi, Andrea Cocci, Fabrizio Di Maida, Riccardo Tellini, Simone Sforza, Andrea Mari, Lorenzo Masieri, Andrea Minervini, Marco Carini, Cristina Scalici Gesolfo

Risultato della ricerca: Articlepeer review

3 Citazioni (Scopus)

Abstract

The aim of the study was to investigate the feasibility of Epidermal Growth Factor Receptor (EGFR) measurement in bladder washings of patients affected by non-muscle-invasive bladder cancer (NMIBC) and its prognostic role in identifying risk subgroups and predicting disease recurrence and progression.
Lingua originaleEnglish
Numero di pagine0
RivistaClinical Genitourinary Cancer
Stato di pubblicazionePublished - 2019

All Science Journal Classification (ASJC) codes

  • Oncology
  • Urology

Fingerprint Entra nei temi di ricerca di 'Epidermal Growth Factor Receptor (EGFR) Cell Expression During Adjuvant Treatment After Transurethral Resection for Non-Muscle-Invasive Bladder Cancer: A New Potential Tool to Identify Patients at Higher Risk of Disease Progression'. Insieme formano una fingerprint unica.

Cita questo